The HCPLive conference coverage page features articles, videos, and expert-led live coverage from major medical meetings throughout the year.
REBALANCE-HF: Greater Splanchnic Nerve Ablation Could Prove Beneficial in HFpEF
October 8th 2023The REBALANCE-HF trial at HFSA 2023 reveals that right greater splanchnic nerve ablation was well-tolerated and safe in patients with HFpEF, with additional analysis shedding light on the proportion of responders to the procedure.
Tegan Medico, MS, MPH, RDN, CNSC: Diet and Nutrition Management in Pediatric Gastric Disease
October 8th 2023The optimization of diet and nutrition support during pediatric patients’ rehabilitation is a strategy in lieu of a comprehensively ideal guideline and requires an appreciation for the individual.
Out-of-Pocket Costs Influence GDMT Uptake in Heart Failure, with Anand Shah, MD, MBA
October 7th 2023Anand Shah, MD, MBA, provides insights into a study he led examining the impact of out-of-pocket costs and insurance type on uptake of GDMT in patients with heart failure with reduced ejection fraction.
In Heart Failure Patients, Spironolactone Linked to Reduced Risk of Dementia, Alzheimers Disease
October 7th 2023A propensity score-matched analysis of data suggests use of spironolactone could reduce the 3-year risk of developing Alzheimer disease or dementia among patients with heart failure with reduced ejection fraction.
Dupilumab Prescriptions for Pediatric EoE Burdened by Prior Authorizations, Delayed Initiation
October 5th 2023An institution's review of prescriptions in the first year since dupilumab's historic FDA approval for eosinopihlic esophagitis shows patients waited a mean 46 days to initiate the biologic therapy.
Guselkumab Produces Long-Lasting Pharmacodynamic Effects, Disease Improvement in PsA
Continued reductions in serum acute phase proteins and collagen degradation proteins observed in patients with psoriatic arthritis receiving guselkumab may be linked to sustained symptom improvements.